Speaking at the 76th session of the UN General Assembly last month, Prime Minister Narendra Modi said: “India has developed the world’s first DNA vaccine.

An m-RNA vaccine is in the final stages of development.” The announcement in the lofty halls of the UNGA in New York refers to a 15-year-old Pune-based pharmaceutical company, Gennova Biopharmaceuticals, the biotech subsidiary of the Rs 6,056-crore Emcure Group, which is developing the country’s first indigenous mRNA Covid-19 vaccine, HGCO19, that is now under advanced human trials. The firm now aims to …

Leave a Reply

Your email address will not be published. Required fields are marked *

An m-RNA vaccine is in the final stages of development.” The announcement in the lofty halls of the UNGA in New York refers to a 15-year-old Pune-based pharmaceutical company, Gennova Biopharmaceuticals, the biotech subsidiary of the Rs 6,056-crore Emcure Group, which is developing the country’s first indigenous mRNA Covid-19 vaccine, HGCO19, that is now under advanced human trials. The firm now aims to

Leave a Reply

Your email address will not be published. Required fields are marked *